Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RPL35 |
| Upstream (Parents) |
|---|
| (<<) CDCP1 → RPL35 |
| (<<) NUDT6 → RPL35 |
| (<<) RDX → RPL35 |
| (<<) RORA → RPL35 |
| (<<) SET → RPL35 |
| Downstream (Children) |
|---|
| RPL35 → CD3EAP (>>) |
| RPL35 → CHAF1A (>>) |
| RPL35 → CLCF1 (>>) |
| RPL35 → CTRB2 (>>) |
| RPL35 → DYNLL1 (>>) |
| RPL35 → E2F6 (>>) |
| RPL35 → EBP (>>) |
| RPL35 → EPHB3 (>>) |
| RPL35 → GNB2 (>>) |
| RPL35 → GNB2L1 (>>) |
| RPL35 → HRAS (>>) |
| RPL35 → IQSEC2 (>>) |
| RPL35 → KIAA0020 (>>) |
| RPL35 → MAT2A (>>) |
| RPL35 → RPIA (>>) |
| RPL35 → RPL26L1 (>>) |
| RPL35 → RPL36 (>>) |
| RPL35 → RPS16 (>>) |
| RPL35 → SH3GLB2 (>>) |
| RPL35 → SLC25A37 (>>) |
| RPL35 → SOX9 (>>) |
| RPL35 → TAF1A (>>) |
| RPL35 → VCP (>>) |
